Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Neovasc Inc. NVCN

Healthcare Medical Instruments & Supplies
Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter... see more

Recent & Breaking News (NDAQ:NVCN)

Neovasc Provides Update on its Tiara™ Mitral Valve Clinical Program

Canada NewsWire December 6, 2016

Mid-Afternoon Market Update: Crude Oil Up 1%; Five Below Shares Rise On Earnings Beat

Benzinga.com  December 2, 2016

Mid-Day Market Update: Smith & Wesson Declines On Weak Forecast; Envision Healthcare Shares Spike Higher

Benzinga.com  December 2, 2016

Mid-Morning Market Update: Markets Mixed; Big Lots Earnings Beat Estimates

Benzinga.com  December 2, 2016

25 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  December 2, 2016

Neovasc and Boston Scientific Reach US$75 Million Agreement

Canada NewsWire December 2, 2016

Boston Scientific Announces Agreement to Acquire Neovasc Advanced Biological Tissue Capabilities

PR Newswire December 2, 2016

Neovasc Receives Regulatory Approval to Initiate TIARA II CE Mark Study

Canada NewsWire November 28, 2016

Neovasc Announces Dismissal of Class Action Lawsuit

PR Newswire November 23, 2016

Neovasc Reports Third Quarter Results for 2016

PR Newswire November 14, 2016

Neovasc to Host Third Quarter 2016 Conference Call

Canada NewsWire November 7, 2016

Medical Equipment Stocks Under Review -- EnteroMedics, Amedica, Neovasc, and ResMed

PR Newswire November 4, 2016

Neovasc's Tiara and Reducer Highlighted at TCT Presentations

Canada NewsWire November 2, 2016

18 Biggest Mid-Day Losers For Tuesday

Benzinga.com  November 1, 2016

Mid-Morning Market Update: Markets Edge Lower; Pfizer Profit Misses Views

Benzinga.com  November 1, 2016

IIROC Trade Resumption - NVC

Canada NewsWire November 1, 2016

IIROC Trade Resumption - Neovasc Inc.

Newsfile November 1, 2016

Neovasc Announces Update in Litigation with CardiAQ

Canada NewsWire November 1, 2016

IIROC Trade Halt - Neovasc Inc.

Newsfile October 31, 2016

Neovasc to Present Tiara and Reducer Data at TCT in Washington DC

PR Newswire October 26, 2016